Dongliang Liu is a Postdoctoral Associate at the Michael E. DeBakey Department of Surgery, Baylor College of Medicine. He holds a Ph.D. from Xinjiang University. He is also a member of the Chinese Society for Immunology, the National Postdoctoral Association, the American Association for Cancer Research, and the China Zoological Society. His research interests include Cancer therapy (especially for pancreatic cancer immunotherapy), Chimeric virus-like particles (VLPs) vaccine (especially for cancer vaccines), Novel antibiotics development including antimicrobial peptides, Epitomics, and multi-epitope peptide vaccine development for pathogenic viruses.